Toggle Main Menu Toggle Search

Open Access padlockePrints

Where are we going? Translational research in hepatic encephalopathy

Lookup NU author(s): Dr James Orr


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Translational medicine, rather than being a unidirectional clinical utilization of basic research discoveries, should be a bidirectional process of cross-fertilization between basic science, medical knowledge and clinical utilization. While steps and processes differ across these branches of research, clear language and proper definitions are prerequisites for effective interaction of researchers to facilitate knowledge development. With respect to Hepatic Encephalopathy, at first glance the areas which require development are around prevention, both to reduce the risk of relapse following an episode of overt HE and to reduce the risk of the first episode of HE. In addition, shortening the duration of episodes of overt HE may also be relevant. Comparisons of treatments and combinations of treatments, acting by different but potentially synergistic mechanisms, are reasonable targets for both basic and applied research.

Publication metadata

Author(s): Amodio P, Montagnese S, Mullen K, Orr JG, Vilstrup H

Publication type: Article

Publication status: Published

Journal: Metabolic Brain Disease

Year: 2016

Volume: 31

Issue: 6

Pages: 1231-1237

Print publication date: 01/12/2016

Online publication date: 09/09/2015

Acceptance date: 02/09/2015

ISSN (print): 0885-7490

ISSN (electronic): 1573-7365

Publisher: Springer


DOI: 10.1007/s11011-015-9728-3


Altmetrics provided by Altmetric